Cargando…

DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle

Progress in whole-genome sequencing using short-read (e.g., <150 bp), next-generation sequencing technologies has reinvigorated interest in high-resolution physical mapping to fill technical gaps that are not well addressed by sequencing. Here, we report two technical advances in DNA nanotechnolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikheikin, Andrey, Olsen, Anita, Leslie, Kevin, Russell-Pavier, Freddie, Yacoot, Andrew, Picco, Loren, Payton, Oliver, Toor, Amir, Chesney, Alden, Gimzewski, James K., Mishra, Bud, Reed, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698298/
https://www.ncbi.nlm.nih.gov/pubmed/29162844
http://dx.doi.org/10.1038/s41467-017-01891-9
_version_ 1783280735283576832
author Mikheikin, Andrey
Olsen, Anita
Leslie, Kevin
Russell-Pavier, Freddie
Yacoot, Andrew
Picco, Loren
Payton, Oliver
Toor, Amir
Chesney, Alden
Gimzewski, James K.
Mishra, Bud
Reed, Jason
author_facet Mikheikin, Andrey
Olsen, Anita
Leslie, Kevin
Russell-Pavier, Freddie
Yacoot, Andrew
Picco, Loren
Payton, Oliver
Toor, Amir
Chesney, Alden
Gimzewski, James K.
Mishra, Bud
Reed, Jason
author_sort Mikheikin, Andrey
collection PubMed
description Progress in whole-genome sequencing using short-read (e.g., <150 bp), next-generation sequencing technologies has reinvigorated interest in high-resolution physical mapping to fill technical gaps that are not well addressed by sequencing. Here, we report two technical advances in DNA nanotechnology and single-molecule genomics: (1) we describe a labeling technique (CRISPR-Cas9 nanoparticles) for high-speed AFM-based physical mapping of DNA and (2) the first successful demonstration of using DVD optics to image DNA molecules with high-speed AFM. As a proof of principle, we used this new “nanomapping” method to detect and map precisely BCL2–IGH translocations present in lymph node biopsies of follicular lymphoma patents. This HS-AFM “nanomapping” technique can be complementary to both sequencing and other physical mapping approaches.
format Online
Article
Text
id pubmed-5698298
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-56982982017-11-24 DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle Mikheikin, Andrey Olsen, Anita Leslie, Kevin Russell-Pavier, Freddie Yacoot, Andrew Picco, Loren Payton, Oliver Toor, Amir Chesney, Alden Gimzewski, James K. Mishra, Bud Reed, Jason Nat Commun Article Progress in whole-genome sequencing using short-read (e.g., <150 bp), next-generation sequencing technologies has reinvigorated interest in high-resolution physical mapping to fill technical gaps that are not well addressed by sequencing. Here, we report two technical advances in DNA nanotechnology and single-molecule genomics: (1) we describe a labeling technique (CRISPR-Cas9 nanoparticles) for high-speed AFM-based physical mapping of DNA and (2) the first successful demonstration of using DVD optics to image DNA molecules with high-speed AFM. As a proof of principle, we used this new “nanomapping” method to detect and map precisely BCL2–IGH translocations present in lymph node biopsies of follicular lymphoma patents. This HS-AFM “nanomapping” technique can be complementary to both sequencing and other physical mapping approaches. Nature Publishing Group UK 2017-11-21 /pmc/articles/PMC5698298/ /pubmed/29162844 http://dx.doi.org/10.1038/s41467-017-01891-9 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Mikheikin, Andrey
Olsen, Anita
Leslie, Kevin
Russell-Pavier, Freddie
Yacoot, Andrew
Picco, Loren
Payton, Oliver
Toor, Amir
Chesney, Alden
Gimzewski, James K.
Mishra, Bud
Reed, Jason
DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle
title DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle
title_full DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle
title_fullStr DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle
title_full_unstemmed DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle
title_short DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle
title_sort dna nanomapping using crispr-cas9 as a programmable nanoparticle
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698298/
https://www.ncbi.nlm.nih.gov/pubmed/29162844
http://dx.doi.org/10.1038/s41467-017-01891-9
work_keys_str_mv AT mikheikinandrey dnananomappingusingcrisprcas9asaprogrammablenanoparticle
AT olsenanita dnananomappingusingcrisprcas9asaprogrammablenanoparticle
AT lesliekevin dnananomappingusingcrisprcas9asaprogrammablenanoparticle
AT russellpavierfreddie dnananomappingusingcrisprcas9asaprogrammablenanoparticle
AT yacootandrew dnananomappingusingcrisprcas9asaprogrammablenanoparticle
AT piccoloren dnananomappingusingcrisprcas9asaprogrammablenanoparticle
AT paytonoliver dnananomappingusingcrisprcas9asaprogrammablenanoparticle
AT tooramir dnananomappingusingcrisprcas9asaprogrammablenanoparticle
AT chesneyalden dnananomappingusingcrisprcas9asaprogrammablenanoparticle
AT gimzewskijamesk dnananomappingusingcrisprcas9asaprogrammablenanoparticle
AT mishrabud dnananomappingusingcrisprcas9asaprogrammablenanoparticle
AT reedjason dnananomappingusingcrisprcas9asaprogrammablenanoparticle